SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
1.930
+0.030 (1.58%)
At close: Oct 8, 2025, 4:00 PM EDT
1.920
-0.010 (-0.52%)
After-hours: Oct 8, 2025, 7:54 PM EDT
SLS Market Cap
SLS has a market cap or net worth of $203.22 million as of October 8, 2025. Its market cap has increased by 161.07% in one year.
Market Cap
203.22M
Enterprise Value
175.51M
1-Year Change
161.07%
Ranking
Category
Stock Price
$1.93
Market Cap Chart
Since January 2, 2018, SLS's market cap has increased from $38.66M to $203.22M, an increase of 425.62%. That is a compound annual growth rate of 23.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 200.07M | 173.32% |
| Dec 31, 2024 | 73.20M | 115.37% |
| Dec 29, 2023 | 33.99M | -30.05% |
| Dec 30, 2022 | 48.59M | -44.69% |
| Dec 31, 2021 | 87.85M | 59.80% |
| Dec 31, 2020 | 54.97M | 162.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 762.53B |
| Johnson & Johnson | 453.30B |
| AbbVie | 405.48B |
| UnitedHealth Group | 327.24B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.89B |